NASDAQ · SERVICES-HEALTH SERVICES · SMALL CAP
Omada Health, Inc. OMDA
3 fiscal years on record · USD · FY2025 reported · SEC filings only
Growth
USD 260.2M
Revenue, FY2025 · full 3-year series below
Revenue $M
Net income $M
FY2025 · Revenue 260.2 · Net income -12.8
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−5 cents
lost on every revenue dollar
Operating margin
Net margin
FY2025 · Operating -4.6% · Net -4.9%
ROE
Not applicable: equity was negative in this period, so return on equity has no meaning.
The 3-year record
3 fiscal years
Every figure from documents filed with the SEC · USD
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
row low → row highnegative
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue $B | 0.3 | 0.2 | 0.1 |
| Operating income $B | −0.0 | −0.0 | −0.1 |
| EBITDA $B | −0.0 | −0.0 | −0.1 |
| Income tax $B | 0.0 | 0.0 | 0.0 |
| Net income $B | −0.0 | −0.0 | −0.1 |
| Free cash flow $B | 0.0 | −0.0 | −0.1 |
| EPS, diluted $ | −0.35 | −6.11 | −9.52 |
| Dividend / sh $ | · | · | · |
| Payout % | · | · | · |
| ROE % | · | · | · |
| Shares out B | 0.06 | 0.01 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 13 reconciliationsAUDITED
Reconciled in 3 of 19 fiscal years. 82 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Health Services
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categoryemerging growth company
Data on record since2023